ALXN
Ensign Peak Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-116,882
| Closed | -$17.9M | – | 1882 |
|
|
2021
Q1 | $17.9M | Sell |
116,882
-47,846
| -29% | -$7.32M | 0.04% | 330 |
|
|
2020
Q4 | $25.7M | Sell |
164,728
-146,174
| -47% | -$22.8M | 0.06% | 276 |
|
|
2020
Q3 | $35.6M | Buy |
310,902
+138,515
| +80% | +$15.9M | 0.09% | 189 |
|
|
2020
Q2 | $19.4M | Sell |
172,387
-23,230
| -12% | -$2.61M | 0.05% | 301 |
|
|
2020
Q1 | $17.6M | Buy |
195,617
+69,950
| +56% | +$6.28M | 0.06% | 247 |
|
|
2019
Q4 | $13.6M | Buy |
+125,667
| New | +$13.6M | 0.04% | 361 |
|